Literature DB >> 17681754

Dual role of tubulin-cytoskeleton in store-operated calcium entry in human platelets.

Pedro C Redondo1, Alan G S Harper, Stewart O Sage, Juan A Rosado.   

Abstract

Two mechanisms for store-operated Ca(2+) entry (SOCE) regulated by two independent Ca(2+) stores, the dense tubular system (DTS) and the acidic stores, have been described in platelets. We have previously suggested that coupling between the type II IP(3) receptor (IP(3)RII) and hTRPC1, involving reorganization of the actin microfilaments, play an important role in SOCE. However, the involvement of the tubulin microtubules, located beneath the plasma membrane, remains unclear. Here we show that the microtubule disrupting agent colchicine reduced Ca(2+) entry stimulated by low concentrations (0.1 U/mL) of thrombin, which activates SOCE mostly by depleting acidic Ca(2+)-store. Consistently, colchicine reduced SOCE activated by 2,5 di-(tertbutyl)-1,4-hydroquinone (TBHQ), which selectively depletes the acidic Ca(2+) stores. In contrast, colchicine enhanced SOCE mediated by depletion of the DTS, induced by high concentrations of thapsigargin (TG), which depletes both the acidic Ca(2+) stores and the DTS, the major releasable Ca(2+) store in platelets. These findings were confirmed by using Sr(2+) as a surrogate for Ca(2+) entry. Colchicine attenuated the coupling between IP(3)RII and hTRPC1 stimulated by thrombin while it enhanced that evoked by TG. Paclitaxel, which induces microtubular stabilization and polymerization, exerted the opposite effects on thrombin- and TG-evoked SOCE and coupling between IP(3)RII and hTRPC1 compared with colchicine. Neither colchicine nor paclitaxel altered the ability of platelets to extrude Ca(2+). These findings suggest that tubulin microtubules play a dual role in SOCE, acting as a barrier that prevents constitutive SOCE regulated by DTS, but also supporting SOCE mediated by the acidic Ca(2+) stores.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17681754     DOI: 10.1016/j.cellsig.2007.06.011

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  5 in total

1.  Engineered nanomedicine for neuroregeneration: light emitting diode-mediated superparamagnetic iron oxide-gold core-shell nanoparticles functionalized by nerve growth factor.

Authors:  Muzhaozi Yuan; Ya Wang; Yi-Xian Qin
Journal:  Nanomedicine       Date:  2019-07-23       Impact factor: 5.307

Review 2.  IP3 receptor signaling and endothelial barrier function.

Authors:  Mitchell Y Sun; Melissa Geyer; Yulia A Komarova
Journal:  Cell Mol Life Sci       Date:  2017-08-12       Impact factor: 9.261

3.  The Actin-Binding Protein Drebrin Inhibits Neointimal Hyperplasia.

Authors:  Jonathan A Stiber; Jiao-Hui Wu; Lisheng Zhang; Igor Nepliouev; Zhu-Shan Zhang; Victoria G Bryson; Leigh Brian; Rex C Bentley; Phillip R Gordon-Weeks; Paul B Rosenberg; Neil J Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-24       Impact factor: 8.311

Review 4.  The regulation of STIM1 by phosphorylation.

Authors:  Eulalia Pozo-Guisado; Francisco Javier Martin-Romero
Journal:  Commun Integr Biol       Date:  2013-09-05

5.  Nicergoline inhibits human platelet Ca(2+) signalling through triggering a microtubule-dependent reorganization of the platelet ultrastructure.

Authors:  T Walford; F I Musa; A G S Harper
Journal:  Br J Pharmacol       Date:  2015-12-05       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.